Barinat 4 (olumiant, baricitinib) 4 mg, 14 pills – alopecia areata, arthritis, COVID

Description

Barinat 4 (olumiant, baricitinib) 4 mg, 14 pills bottle

LIMITED SUPPLY – USA STOCK ONLY

Baricitinib, sold under the brand name Olumiant among others, is a medication used for the treatment of rheumatoid arthritis, alopecia areata, and COVID-19. It acts as an inhibitor of janus kinase (JAK), blocking the subtypes JAK1 and JAK2.

• The list price¹ of Olumiant is $2,497.20 for a 30-day supply of 2 mg tablets or $4,994.40 for a 30-day supply of 4 mg tablets, but the amount you pay will largely depend on your insurance plan.

FDA Approves Lilly and Incyte’s OLUMIANT® (baricitinib) As First and Only Systemic Medicine for Adults with Severe Alopecia Areata

The efficacy and safety of baricitinib in alopecia areata was studied in two randomized, double-blind, placebo-controlled trials (Trial AA-1 and Trial AA-2) with participants who had at least 50% scalp hair loss as measured by the Severity of Alopecia Tool for more than six months. Participants in these trials received either a placebo, 2 milligrams of Olumiant, or 4 milligrams of Olumiant every day. The primary measurement of efficacy for both trials was the proportion of patients who achieved at least 80% scalp hair coverage at week 36.